“We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya

<strong>Background</strong> Adherence to anti-malarial medication is highly variable but frequently suboptimal. Numerous interventions with a variety of methodological approaches have been implemented to address the problem. A recently conducted, randomized, controlled trial in western K...

Full description

Bibliographic Details
Main Authors: Jones, C, Talisuna, A, Snow, R, Zurovac, D
Format: Journal article
Published: BioMed Central 2018
_version_ 1797067788878086144
author Jones, C
Talisuna, A
Snow, R
Zurovac, D
author_facet Jones, C
Talisuna, A
Snow, R
Zurovac, D
author_sort Jones, C
collection OXFORD
description <strong>Background</strong> Adherence to anti-malarial medication is highly variable but frequently suboptimal. Numerous interventions with a variety of methodological approaches have been implemented to address the problem. A recently conducted, randomized, controlled trial in western Kenya evaluated the effects of short message service (SMS) reminders on paediatric adherence to artemether–lumefantrine (AL) and found over 97% adherence rates in both intervention and control arms. The current study was undertaken to explore participants’ experiences in the trial and identify the factors contributing to the high adherence rates. <strong>Methods</strong> In July 2016, 5 months after the trial completion, focus group discussions (FGDs) were undertaken with caregivers of children who had been treated in the intervention (n = 2) or control (n = 2) arms and who, post-trial, had received malaria treatment from the same facilities. The FGDs explored similarities and differences in perceptions and experiences of the care they received during and after the trial. <strong>Results</strong> Intervention-arm participants reported that SMS messages were effective dosing reminders. Participants from both arms reported that trial instructions to keep empty AL packs for verification during a home visit by a health worker affected their dosing and adherence practices. Differences between trial and post-trial treatment experiences included: administration of the first AL dose by health workers with demonstration of dispersible tablets dilution; advice on what to do if a child vomited; clear instructions on timing of dosing with efforts made to ensure understanding; and, information that dose completion was necessary with explanation provided. Participants reported that after the trial AL was not available at facilities, constraining their ability to adhere to recommended malaria treatment. They emphasized receiving respectful and personal treatment from trial health workers contributing to perceptions of high quality care and enhanced readiness to adhere to dosing instructions. <strong>Conclusions</strong> This study highlights the complex range of factors that influence AL adherence. The results suggest that in addition to standardized definitions and measurement of adherence, and the influence of enrolment procedures, AL adherence trials need to take account of how intervention impact can be influenced by differences in the quality of care received under trial and routine conditions.
first_indexed 2024-03-06T22:01:22Z
format Journal article
id oxford-uuid:4eb4bd96-0106-48ea-9c8f-65932a1207e3
institution University of Oxford
last_indexed 2024-03-06T22:01:22Z
publishDate 2018
publisher BioMed Central
record_format dspace
spelling oxford-uuid:4eb4bd96-0106-48ea-9c8f-65932a1207e32022-03-26T16:02:46Z“We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western KenyaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4eb4bd96-0106-48ea-9c8f-65932a1207e3Symplectic Elements at OxfordBioMed Central2018Jones, CTalisuna, ASnow, RZurovac, D<strong>Background</strong> Adherence to anti-malarial medication is highly variable but frequently suboptimal. Numerous interventions with a variety of methodological approaches have been implemented to address the problem. A recently conducted, randomized, controlled trial in western Kenya evaluated the effects of short message service (SMS) reminders on paediatric adherence to artemether–lumefantrine (AL) and found over 97% adherence rates in both intervention and control arms. The current study was undertaken to explore participants’ experiences in the trial and identify the factors contributing to the high adherence rates. <strong>Methods</strong> In July 2016, 5 months after the trial completion, focus group discussions (FGDs) were undertaken with caregivers of children who had been treated in the intervention (n = 2) or control (n = 2) arms and who, post-trial, had received malaria treatment from the same facilities. The FGDs explored similarities and differences in perceptions and experiences of the care they received during and after the trial. <strong>Results</strong> Intervention-arm participants reported that SMS messages were effective dosing reminders. Participants from both arms reported that trial instructions to keep empty AL packs for verification during a home visit by a health worker affected their dosing and adherence practices. Differences between trial and post-trial treatment experiences included: administration of the first AL dose by health workers with demonstration of dispersible tablets dilution; advice on what to do if a child vomited; clear instructions on timing of dosing with efforts made to ensure understanding; and, information that dose completion was necessary with explanation provided. Participants reported that after the trial AL was not available at facilities, constraining their ability to adhere to recommended malaria treatment. They emphasized receiving respectful and personal treatment from trial health workers contributing to perceptions of high quality care and enhanced readiness to adhere to dosing instructions. <strong>Conclusions</strong> This study highlights the complex range of factors that influence AL adherence. The results suggest that in addition to standardized definitions and measurement of adherence, and the influence of enrolment procedures, AL adherence trials need to take account of how intervention impact can be influenced by differences in the quality of care received under trial and routine conditions.
spellingShingle Jones, C
Talisuna, A
Snow, R
Zurovac, D
“We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya
title “We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya
title_full “We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya
title_fullStr “We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya
title_full_unstemmed “We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya
title_short “We were being treated like the Queen”: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya
title_sort we were being treated like the queen understanding trial factors influencing high paediatric malaria treatment adherence in western kenya
work_keys_str_mv AT jonesc wewerebeingtreatedlikethequeenunderstandingtrialfactorsinfluencinghighpaediatricmalariatreatmentadherenceinwesternkenya
AT talisunaa wewerebeingtreatedlikethequeenunderstandingtrialfactorsinfluencinghighpaediatricmalariatreatmentadherenceinwesternkenya
AT snowr wewerebeingtreatedlikethequeenunderstandingtrialfactorsinfluencinghighpaediatricmalariatreatmentadherenceinwesternkenya
AT zurovacd wewerebeingtreatedlikethequeenunderstandingtrialfactorsinfluencinghighpaediatricmalariatreatmentadherenceinwesternkenya